Signal Transduction Pathways Mediated by Secreted and Non-Secreted Forms of Intact Insulin-Like Growth Factor Binding Protein-3 (IGFBP-3) and Its 1-97 N-Terminal Fragment in PC-3 Human Prostate Cancer Cells

Hanief Mohammad Shahjee, Benjamin Kefas, Nisan Bhattacharyya, Mohamed K. Radwan

Department of Biochemistry and Biophysics, University of Rochester Medical Center, Rochester, USA.
Diabetes Branch, NIDDK, National Institutes of Health, Bethesda, USA.
Division of Neuro-Oncology, Neurology Department, University of Virginia Health System, Charlottesville, USA.

DOI: 10.4236/jct.2013.48152                

Abstract

Our previous results indicated that both the secreted and the intracellular form of full length and 1-97 N-terminal fragment of IGFBP-3 induce apoptosis in PC-3 human prostate cancer cells in an IGF-dependent and independent manner. This study was undertaken to delineate possible down-stream signaling pathways that are involved in this process. Intact IGFBP-3 and its N-terminal 1-97 fragments with or without a signal propeptide were fused to YFP and expressed in PC-3 human prostate cancer cells. In some cases, the putative IGF-binding site was presented in full length IGFBP-3 and its N-terminal fragment was also mutated. Extent of apoptosis was quantified using FACS. Up-regulation of total Stat-1 and activation of phospho-Stat-1 were shown by western blot. TGF-β signal was measured by luciferase reporter assay. Results from inhibitor studies indicated that both the Caspase 8 and caspase 9 pathways are involved in IGFBP-3 (non-secreted form) which induced apoptosis in PC-3 cells. Exogenous addition of IGFBP-3 to PC-3 cells increased Stat-1 protein expression/tyrosine phosphorylation. Interestingly, results also showed that knockdown of Stat-1 by siRNA potentiated the IGFBP-3 induced apoptosis in PC-3 cells. In addition, both full-length IGFBP-3 and its 1-97 Nterminal fragments inhibited TGF-β signaling in these cells. This is the first report that compares the signal transduction pathways involved in apoptotic pathways mediated by IGFBP-3 in PC-3 human prostate cancer cells. Non-secreted form of full length IGFBP-3 and its N-terminal fragments induced apoptosis in PC-3 cells via activation of caspase 8 and caspase 9. Although, only non-secreted form of IGFBP-3 is involved in inducing apoptosis in PC-3 cells via caspase 8 and caspase 9 activation pathways but both secreted and non-secreted forms of IGFBP-3 are involved in modulating Stat-1 and TGF-β pathways to induce apoptotic actions in PC-3 cells. Non-secreted intact IGFBP-3 and its N-terminal fragments induced apoptosis in PC-3 cells via activation of caspase 8 and caspase 9 pathways. Modulation in STAT-1 and TGF-β pathways may also be important for IGFBP-3 induced apoptosis in PC-3 cells in general. These studies clearly demonstrate that secreted and non-secreted FL and 1-97 N-terminal fragments induce apoptosis in PC-3 cells by regulating different mechanistic pathways.

Keywords

N-Terminal Fragment; Apoptosis; Caspases; Human Prostate Cancer Cells

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	T. Laursen, A. Flyvbjerg, J. O. L. Jorgensen and R. C Baxter, “Stimulation of the 150-Kilodalton Insulin-Like Growth Factor-Binding Protein-3 Ternary Complex by Continuous and Pulsatile Patterns of Growth Hormone (GH) Administration in GH-Deficient Patients,” The Journal of Clinical Endocrinology & Metabolism, Vol. 85, No. 11, 2000, pp. 4310-4314. http://dx.doi.org/10.1210 /jc.85.11.4310
[2]	M. M. Rechler and D. R. Clemmons, “Regulatory Actions of Insulin-Like Growth Factor-Binding Proteins,” Trends Endocrinology Metabolism, Vol. 9, No. 5, 1998, pp. 176-183. http://dx.doi.org/10. 1016/S1043-2760(98)00047-2
[3]	S. M. Firth and R. C. Baxter, “Cellular Actions of the Insulin-Like Growth Factor Binding Proteins,” Endocrinology Review, Vol. 23, No. 6, 2002, pp. 824-854. http://dx.doi.org/10.1210/er.2001-0033
[4]	J. Hong, G. Zhang, F. Dong and M. M. Rechler, “Insulin-Like Growth Factor (IGF)-Binding Protein-3 Mutants That Do Not Bind IGF-I or IGF-II Stimulate Apoptosis in Human Prostate Cancer Cells,” Journal of Biological Chemistry, Vol. 277, No. 12, 2002, pp. 10489-10497. http://dx.doi.org/10.1074/ jbc.M109604200
[5]	N. Bhattacharyya, K. Pechhold, H. Shahjee, et al., “Non-Secreted Insulin-Like Growth Factor Binding Protein-3 (IGFBP-3) Can Induce Apoptosis in Human Prostate Cancer Cells by IGF-Independent Mechanisms without Being Concentrated in the Nucleus,” Journal of Biological Chemistry, Vol. 281, No. 34, 2006, pp. 24588-24601. http://dx.doi.org/10.1074/jbc.M509463200
[6]	R. Rajah, B. Valentinis and P. Cohen, “Insulin-Like Growth Factor (IGF)-Binding Protein-3 Induces Apoptosis and Mediates the Effects of Transforming Growth Factor-Beta1 on Programmed Cell Death through a p53-and IGF-Independent Mechanism,” Journal of Biological Chemistry, Vol. 272, No. 18, 1997, pp. 12181-12188. http://dx.doi.org/10.1074/jbc.272.18.12181
[7]	A. J. Butt, K. A. Fraley, S. M. Firth and R. C. Baxter, “IGF-Binding Protein-3-Induced Growth Inhibition and Apoptosis Do Not Require Cell Surface Binding and Nuclear Translocation IN Human Breast Cancer Cells,” Endocrinology, Vol. 143, No. 7, 2002, pp. 2693-2699. http://dx.doi.org/10.1210 /en.143.7.2693
[8]	K.W.Lee, L. Ma, X. Yan, et al., “Rapid Apoptosis Induction by IGFBP-3 Involves an Insulin-Like Growth FactorIndependent Nucleomitochondrial Translocation of RXRalpha/Nur77,” Journal of Biological Chemistry, Vol. 280, No. 17, 2005, pp. 16942-16948. http://dx.doi.org/10.1074/jbc.M412757200
[9]	L. J. Schedlich, T. F. Young, S. M. Firth and R. C. Baxter, “Insulin-Like Growth Factor-Binding Protein (IGFBP)-3 and IGFBP-5 Share a Common Nuclear Transport Pathway in T47D Human Breast Carcinoma Cells,” Journal of Biological Chemistry, Vol. 273, No. 29, 1998, pp. 18347-18352. http://dx.doi.org/ 10.1074/jbc.273.29.18347
[10]	A. Spagnoli, M. Torello, S. R. Nagalla, et al., “Identification of STAT-1 as a Molecular Target of IGFBP-3 in the Process of Chondrogenesis,” Journal of Biological Chemistry, Vol. 277, No. 21, 2002, pp. 18860-18867. http://dx.doi.org/10.1074/jbc.M200218200
[11]	G. Zappalà and M. M. Rechler, “IGFBP-3, Hypoxia and TNF-Alpha Inhibit Adiponectin Transcription,” Biochemical and Biophysical Research Communications, Vol. 382, No. 4, 2009, pp. 785-789. http://dx.doi.org/10.1016/j.bbrc. 2009.03.112
[12]	S. M. Leal, S. S. Huang and J. S. Huang, “Interactions of High Affinity Insulin-Like Growth Factor-Binding Proteins with the Type V Transforming Growth Factor-Betareceptor in Mink Lung Epithelial Cells,” Journal of Biological Chemistry, Vol. 274, No. 10, 1999, pp. 6711-6717. http://dx.doi.org/10. 1074/ jbc.274.10.6711
[13]	L. C. Giudice, E. M. Farrell, H. Pham, et al., “InsulinLike Growth Factor Binding Proteins in Maternal Serum throughout Gestation and in the Puerperium: Effects of a Pregnancy-Associated Serum Protease Activity,” The Journal of Clinical Endocrinology & Metabolism, Vol. 71, No. 4, 1990, pp. 806-816. http://dx.doi.org/10.1210/jcem-71-4-806
[14]	P. Angelloz-Nicoud, C. Lalou and M. Binoux, “Prostate Carcinoma (PC-3) Cell Proliferation Is Stimulated by the 22 - 25-kDa Proteolytic Fragment (1-160) Andinhibited by the 16-kDa Fragment (1 - 95) of Recombinant Human Insulin-Like Growth Factor Binding Protein-3,” Growth Hormone & IGF Research, Vol. 8, No. 1, 1998, pp. 71-75.
[15]	H. Shahjee, N. Bhattacharyya and G. Zappala, “An N-Terminal Fragment of Insulin-Like Growth Factor Binding Protein-3 (IGFBP-3) Induces Apoptosis in Human Prostate Cancer Cells in an IGF-Independent Manner,” Growth Hormone & IGF Research, Vol. 18, No. 3, 2008, pp. 188-197.
[16]	Y. Oh, H. L. Muller, L. Ng and R. G. Rosenfeld, “Transforming Growth Factor-Beta-Induced Cell Growth Inhibition in Human Breast Cancer Cells Is Mediated through Insulin-Like Growth Factor-Binding Protein-3 Action,” Journal of Biological Chemistry, Vol. 270, No. 23, 1995, pp. 13589-13592. http://dx.doi.org/ 10.1074/jbc.270.23.13589
[17]	Z. S. Gucev, Y. Oh, K. M. Kelley and R. G. Rosenfeld, “Insulin-Like Growth Factor Binding Protein 3 Mediates Retinoic Acidand Transforming Growth Factor Beta 2-Induced Growth Inhibition in Human Breast Cancer Cells,” Cancer Research, Vol. 56, 1996, pp. 1545-1550.
[18]	G. R. Devi, D. L. Graham, Y. Oh and R. G. Rosenfeld, “Effect of IGFBP-3 on IGF and IGF-Analogue-Induced Insulin-Like Growth Factor-I Receptor (IGFIR) Signalling,” Growth Hormone & IGF Research, Vol. 11, No. 4, 2001, pp. 231-239. http://dx.doi.org/10.1054/ghir.2001.0231
[19]	C. Lalou, C. Lassarre and M. Binoux, “A Proteolytic Fragment of Insulin-Like Growth Factor (IGF) Binding Protein-3 That Fails to Bind IGFs Inhibits the Mitogenic Effects of IGF-I and Insulin,” Endocrinology, Vol. 137, No. 8, 1996, pp. 3206-3212. http://dx.doi.org/10.1210/en.137.8.3206
[20]	K. W. Colston, C. M. Perks, S. P. Xie and J. M. Holly, “Growth Inhibition of Both MCF-7 and Hs578T Human Breast Cancer Cell Lines by Vitamin D Analogues Is Associated with Increased Expression of Insulin-Like Growth Factor Binding Protein-3,” Journal of Molecular Endocrinology, Vol. 20, 1998, pp. 157-162.
[21]	A. J. Butt, S. M. Firth, M. A. King and R. C. Baxter, “Insulin-Like Growth Factor-Binding Protein-3 Modulates Expression of Bax and Bcl-2 and Potentiates p53-Independent Radiation-Induced Apoptosis in Human Breast Cancer Cells,” Journal of Biological Chemistry, Vol. 275, No. 50, 2000, pp. 39174-39181. http://dx.doi.org/10.1074/jbc.M908888199
[22]	B. J. Boyle, X. Y. Zhao, P. Cohen and D. Feldman, “Insulin-Like Growth Factor Binding Protein-3 Mediates 1 Alpha, 25-Dihydroxyvitamin d(3) Growth Inhibition in the LNCaP Prostate Cancer Cell Line through p21/ WAF1,” Journal of Urology, Vol. 165, No. 4, 2001, pp. 1319-1324. http://dx.doi.org /10.1016/S0022-5347(01)69892-6
[23]	D. R. Green, “Apoptotic Pathways: The Roads to Ruin,” Cell, Vol. 94, No. 6, 1998, pp. 695-698. http://dx.doi.org/10.1016/S0092-8674(00)81728-6
[24]	S. Fanayan, S. M. Firth, A. J. Butt and R. C. Baxter, “Growth Inhibition by Insulin-Like Growth Factor-Binding Protein-3 in T47d Breast Cancer Cells Requires Transforming Growth Factor-Beta (TGF-Beta) and the Type II TGF-Beta Receptor,” Journal of Biological Chemistry, Vol. 275, No. 50, 2000, pp. 39146-39151. http://dx.doi.org/10.1074/jbc.M006964200
[25]	S. Fanayan, S. M. Firth and R. C. Baxter, “Signaling through the Smad Pathway by Insulin-Like Growth Factor-Binding Protein-3 in Breast Cancer Cells. Relationship to Transforming Growth Factor-Beta 1 Signaling,” Journal of Biological Chemistry, Vol. 277, No. 9, 2002, pp. 7255-7261. http://dx.doi.org/ 10.1074/jbc.M108038200